Food and Drug Administration
October 21, 2004
Briefing Information
Topic I - FDA's Current Thinking on Reentry of Donors Deferred for Repeated Detection of Antibody to Hepatitis B Core Antigen (HTM) (PDF) (Word)
Topic II - The Potential Risk of Simian Foamy Virus Transmission by Blood Transfusion (HTM) (PDF) (Word)